1. Home
  2. DCTH vs AIP Comparison

DCTH vs AIP Comparison

Compare DCTH & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • AIP
  • Stock Information
  • Founded
  • DCTH 1988
  • AIP 2003
  • Country
  • DCTH United States
  • AIP United States
  • Employees
  • DCTH N/A
  • AIP N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • AIP Semiconductors
  • Sector
  • DCTH Health Care
  • AIP Technology
  • Exchange
  • DCTH Nasdaq
  • AIP Nasdaq
  • Market Cap
  • DCTH 352.0M
  • AIP 277.9M
  • IPO Year
  • DCTH N/A
  • AIP 2021
  • Fundamental
  • Price
  • DCTH $11.85
  • AIP $10.48
  • Analyst Decision
  • DCTH Strong Buy
  • AIP Strong Buy
  • Analyst Count
  • DCTH 4
  • AIP 4
  • Target Price
  • DCTH $21.50
  • AIP $13.00
  • AVG Volume (30 Days)
  • DCTH 346.0K
  • AIP 242.4K
  • Earning Date
  • DCTH 11-08-2024
  • AIP 02-18-2025
  • Dividend Yield
  • DCTH N/A
  • AIP N/A
  • EPS Growth
  • DCTH N/A
  • AIP N/A
  • EPS
  • DCTH N/A
  • AIP N/A
  • Revenue
  • DCTH $22,644,000.00
  • AIP $54,739,000.00
  • Revenue This Year
  • DCTH $1,605.13
  • AIP $8.13
  • Revenue Next Year
  • DCTH $111.67
  • AIP $19.08
  • P/E Ratio
  • DCTH N/A
  • AIP N/A
  • Revenue Growth
  • DCTH 945.91
  • AIP 4.53
  • 52 Week Low
  • DCTH $3.70
  • AIP $4.83
  • 52 Week High
  • DCTH $13.30
  • AIP $10.60
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 51.68
  • AIP 60.68
  • Support Level
  • DCTH $10.75
  • AIP $8.72
  • Resistance Level
  • DCTH $11.59
  • AIP $10.35
  • Average True Range (ATR)
  • DCTH 0.70
  • AIP 0.58
  • MACD
  • DCTH -0.11
  • AIP -0.02
  • Stochastic Oscillator
  • DCTH 24.56
  • AIP 65.66

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About AIP Arteris Inc.

Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

Share on Social Networks: